Today: 18.Jun.2018
Radioisotopes and Nuclear Medicine
Radioisotopes and Nuclear Medicine (90)

16.Apr.2018 Written by

Australian Nuclear Science and Technology Organisation, ANSTO: This is a compilation of uses of radioisotopes in nuclear medicine, industry, agriculture, archeology, art research, research climate change over thousands of years and many other applications. Uses of radioisotopes present a much larger industry than nuclear energy itself.

15.Apr.2018 Written by

U.S. Atomic Energy Commission, Glenn Seaborg, Chairman: Nuclear energy is playing a vital role in the life of every man, woman, and child in the United States today, (1960s). In the years ahead it will affect increasingly all the peoples of the earth. It is essential that all Americans gain an understanding of this vital force if they are to discharge thoughtfully their responsibilities as citizens and if they are to realize fully the myriad benefits that nuclear energy offers them. From the 1960s to the 2010s, the United States lost its way with nuclear energy and promoting the many outstanding by-products due to fear mongering by anti-nuclear organizations and a government that let them succeed. Much of the rest of the world is determined to use the tremendous benefits of nuclear energy and radioisotopes for nuclear medicine etc. to the fullest extent possible. Will the United States get back on track for leadership in science to help the world? - John Shanahan, President of Environmentalists for Nuclear - USA.

09.Apr.2018 Written by

Van Zyl de Villiers, Past-President World Council on Isotopes, April 2018: The production and supply of key medical radioisotopes, especially molybdenum-99, but also iodine-131 and xenon-133, continue to be of major interest to the isotope industry, the healthcare community and policy makers. The main players have been very successful in improving security of supply after the shortages experienced during 2009-2010, but also underline that the present form of the 99Mo/99mTc market remains economically unsustainable. See www.wci-ici.org for all newsletter issues.

19.Mar.2018 Written by

Robert Schenter, physicist: He specialized in the production of radioisotopes in reactors for nuclear medicine. Much of nuclear medicine depends on a steady supply of an isotope called molybdenum-99—“Mo-99” for short. A by-product of nuclear fission, Mo-99 decays to produce another radioactive substance, technetium-99m, which is employed in more than 16 million nuclear imaging procedures every year in the United States alone, including sentinel node biopsies in cancer surgery, bone scans, and cardiac stress tests.

17.Mar.2018 Written by

M. Alex Brown, Ph.D. radiochemistry: Medical isotopes are a class of radioactive isotopes used by hospitals to monitor the body’s functions and destroy cancerous tissues. They’re different from x-rays and CT scans that use accelerators to generate radiation. As of 2012 nearly 40 million people every year receive a diagnostic procedure with a medical isotope in what’s estimated to be a $5 billion/year industry, according to world-nuclear.org. Radiation therapy extends to the treatment of non-Hodgkins lymphoma, HIV, liver cancer, thyroid cancer, breast cancer, and more.

08.Mar.2018 Written by

David Kramer: The first US production in 30 years of molybdenum-99, the parent isotope of the most widely used medical radioisotope, is expected to begin within weeks after federal regulators approved a manufacturing process developed by Wisconsin-based NorthStar Medical Radioisotopes. NorthStar received $25 million in matching funds from DOE for development of the neutron capture process and $14.8 million of an expected $25 million total for its accelerator approach.

03.Feb.2018 Written by

Society of Nuclear Medicine and Molecular Imaging: A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California Los Angeles (UCLA). The study utilizes PET/CT with gallium-68 prostate-specific membrane antigen (68Ga-PSMA-11).

30.Dec.2017 Written by

CRC Press, Edited by Michael Poeschl and Leo M. L. Nollet: A comprehensive, fairly easy to read and understand treatise by 31 experts from around the world on the exciting topics of radionuclides, radiation, radioactivity and their presence and uses in the environment and food. Contributors and Editors are from Australia, Belgium, Czech Republic, England, Italy, Portugal, Saudi Arabia, Slovakia, Spain, Switzerland, and the USA. Topics: What are Radionuclides, Sources, Radioactivity in the Air, in Water, in Soils, Transport Processes and Modeling, in Foodstuffs and Food Raw Material, Radiation Detection Methods, Unmasking Illicit Trafficking of Nuclear and Radioactive Materials, Radiation Protection, Regulations, Food Irradiation.

28.Oct.2017 Written by

Leonne Prompers, Medical manager, nuclear medicine Physician bij Zuyderland: EANM Brochure - Principles and Practice of PET/CT, Part 2 A Technologist's Guide with 41 contributing authors. Principles of PET radiochemistry. Clinical applications of PET/CT in oncology. Clinical applications of PET/CT in infection and inflammation. Clinical applications of PET/CT in cardiology. Clinical applications of PET/CT in neurology.

28.Oct.2017 Written by

Bernard Songy, Médecin, Cardiologie nucléaire, David Lussato, M.D., Mohamed Guernou, Médecin nucléaire, Gil Kovalski Ph.D. Biomedical Engineering: Description of nuclear medicine practice at Centre Cardiologique du Nord, (CCN) Paris, France.

Newsletter Subscription

  • Latest
  • Popular
  • Edgar Ocampo Tellez: El propósito de este…
  • Alexander Hellemans, IEEE Spectrum: As soon as…
  • Vaclav Smil, Czech-Canadian scientist and policy analyst.…
  • IEEE SPECTRUM, The Institute of Electrical and…
  • Nadine Freischlad, writer for Mongabay Series: In…
  • Edgar Ocampo Tellez: El propósito de este…